Evaluating sirolimus-based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation.
Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. reuben.arasaratnam@bcm.edu.
R J
RJ
Arasaratnam
D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D020123:Sirolimus / Q000627:therapeutic use*
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir; D020123:Sirolimus